Blurbs

BTIG Thinks Viewray’s Stock is Going to Recover

BTIG analyst Marie Thibault reiterated a Buy rating on Viewray (VRAYResearch Report) today and set a price target of $9.00. The company’s shares closed last Wednesday at $3.83, close to its 52-week low of $3.43.

According to TipRanks.com, Thibault is a 4-star analyst with an average return of 18.7% and a 29.0% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Edwards Lifesciences, and Irhythm Technologies.

Viewray has an analyst consensus of Strong Buy, with a price target consensus of $8.00.

See today’s best-performing stocks on TipRanks >>

The company has a one-year high of $8.25 and a one-year low of $3.43. Currently, Viewray has an average volume of 1.48M.

Based on the recent corporate insider activity of 40 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of VRAY in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

ViewRay, Inc. engages in the design, manufacture and market magnetic resonance imaging (MRI) system. It develops MRIdian to address the key limitations of existing external-beam radiation therapy technologies, and employs MRI-based technology to provide real-time imaging that clearly defines the targeted tumor from the surrounding soft tissue, and other critical organs, both before and during radiation treatment delivery. The company was founded by Dinara Akzhigitova on September 6, 2013 and is headquartered in Oakwood Village, OH.

Read More on VRAY:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos
Videos

Latest News Feed